01273 704473

info@novuscomms.com

01273 704473

info@novuscomms.com

#TSP TruSpine Technologies PLC – Half-year Report December 30, 2025 – Posted in: Uncategorized

The Company continues to be in a pre-revenue development phase and remains loss-making.  The loss before taxation for the six months to 30 September 2025 was £335k (2024: £410k) after administrative expenses of £335k (2024: £410k). Consolidated net assets as at 30 September 2025 amounted to £1.83 million (2024: £2.33 million) including a bank balance of £33k as at 30 September 2025 (2024: £51k). As highlighted in recent shareholder communications, until discussions regarding the long-term…

Continue reading

#TSP TruSpine Technologies PLC – Delay to the publication of accounts & Suspension October 1, 2025 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces a delay to the completion and publication of its audited accounts for the year to 29 March 2025. Accordingly, pursuant to Rule 5.1 of the AQSE Growth Market Access Rulebook, a temporary suspension of trading in the Company’s shares will take effect from 08:00 today (1 October 2025). The Company anticipates that it will be in a position to publish…

Continue reading

#ELEG Electric Guitar PLC – Shareholdings and total voting rights August 28, 2024 – Posted in: Electric Guitar Plc (ELEG)

Electric Guitar PLC (LSE: ELEG), the digital marketing and advertising company providing first-party data solutions, has been informed that with the issue of 9,834,521 ordinary shares of 0.5p each in the Company pursuant to the acquisition of Mymyne Limited announced on 9 August 2024 (“Initial Consideration Shares”) and their admission to trading on AIM today, two directors of the Company have received Initial Consideration Shares in the Company as announced on 9 August 2024 and…

Continue reading

#TSP TruSpine Technologies PLC – Convertible Loan Note Extension & RPT July 24, 2024 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, that further to the announcement on 28 March 2024, the Company has extended the maturity date of the convertible loan note (“CLN”) to 30 June 2025. All other terms of the CLN remain unchanged. Related Party Transaction The extension of maturity date of the CLN (the “Transaction”) is a related party transaction for the purposes of Rule 4.6 of the AQSE…

Continue reading

#TSP TruSpine Technologies PLC – Convertible Loan Note Conversion & Issue of Equity June 5, 2024 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that, further to the announcement on 26 March 2024, the Company has elected to convert the Lender CLN Subscription of £200,000 into 13,333,333 new ordinary shares at a price of 1.5 pence per share (“CLN Shares”) pursuant to the terms of the CLN Instrument.   Admission   Application has been made for the CLN Shares to be admitted to trading…

Continue reading